Yarmolinsky, James

The MR-Base platform supports systematic causal inference across the human phenome

Hemani, G., Zheng, J., Elsworth, B., Wade, K. H., Haberland, V., Baird, D., Laurin, C., Burgess, S., Bowden, J., Langdon, R., et al. (2018) · eLife

Genetic Associations and EpidemiologyBioinformatics and Genomic Networks

Cited by 7,959

Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement

Skrivankova, V. W., Richmond, R. C., Woolf, B. A. R., Yarmolinsky, J., Davies, N. M., Swanson, S. A., VanderWeele, T. J., Higgins, J. P. T., Timpson, N. J., Dimou, N., et al. (2021) · JAMA

Meta-analysis and systematic reviewsGenetic Associations and Epidemiology

Cited by 3,994

Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases.

Zheng, J., Haberland, V., Baird, D., Walker, V., Haycock, P., Hurle, M., Gutteridge, A., Erola, P., Liu, Y., Luo, S., et al. (2019) · Nature Genetics

Genetic Associations and EpidemiologyBioinformatics and Genomic Networks

Cited by 812

Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer

Yarmolinsky, J., Bull, C. J., Vincent, E. E., Robinson, J., Walther, A., Smith, G. D., Lewis, S. J., Relton, C. L., & Martin, R. M. (2020) · JAMA

Cancer, Lipids, and MetabolismBRCA gene mutations in cancer

Cited by 124

Effect of tea on blood pressure for secondary prevention of cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials

Yarmolinsky, J., Gon, G., & Edwards, P. (2015) · Nutrition Reviews

Tea Polyphenols and EffectsBlood Pressure and Hypertension Studies

Cited by 80

Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study

Fang, S., Yarmolinsky, J., Gill, D., Bull, C. J., Perks, C. M., the PRACTICAL Consortium, Davey Smith, G., Gaunt, T. R., & Richardson, T. G. (2023) · PLOS Medicine

Genetic Associations and EpidemiologyLipoproteins and Cardiovascular Health

Cited by 55

Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancers

Smith-Byrne, K., Hedman, Å., Dimitriou, M., Desai, T., Sokolov, A. V., Schioth, H. B., Koprulu, M., Pietzner, M., Langenberg, C., Atkins, J., et al. (2024) · Nature Communications

Genetic Associations and EpidemiologyCancer Genomics and Diagnostics

Cited by 33